Anxiety treatment serving Boynton Beach — exposure-based CBT, in-house psychiatry.

RECO Health sits twelve minutes south of Boynton Beach on Federal Highway, close enough that Renaissance Commons and Ocean Ridge residents can attend PHP or IOP without leaving home. The program runs disorder-specific protocols — ERP for OCD, interoceptive exposure for panic, graded in-vivo work for social anxiety — with in-house psychiatry managing SSRI dosing. Progress is tracked on GAD-7, PDSS, LSAS, or Y-BOCS rather than clinician impression.

Boynton Beach sits roughly seven miles north of RECO Health’s Delray Beach campus along Federal Highway, a twelve-minute drive that puts partial hospitalization and intensive outpatient care closer than most local errands. For residents in Renaissance Commons, Ocean Ridge, Quantum Park, Hunters Run, or Briny Breezes, structured anxiety treatment does not require relocating, taking indefinite leave from work, or leaving family behind. It fits into an existing week — mornings on the clinical floor, afternoons and evenings at home.

Disorder-specific assessment before treatment starts

“Anxiety” is a presenting symptom, not a treatment plan. RECO’s intake distinguishes the DSM-5-TR diagnoses that share the label but respond to different protocols: generalized anxiety disorder, panic disorder, social anxiety disorder, and obsessive-compulsive disorder. Severity and target symptoms are quantified at intake using GAD-7 for generalized anxiety, the Panic Disorder Severity Scale (PDSS) for panic frequency and functional impairment, the Liebowitz Social Anxiety Scale (LSAS) for social anxiety, and the Y-BOCS for OCD obsessions and compulsions.

The distinction changes what happens next. Generalized anxiety responds to worry-focused CBT and applied relaxation; OCD requires Exposure and Response Prevention with hierarchies built around specific obsessions; panic requires interoceptive exposure to bodily sensations the client has learned to fear; social anxiety collapses if it is run as a generic “anxiety group” without graded in-vivo exposure. Every treatment plan at RECO names the primary diagnosis, the specific measure that will track it, and the target score at discharge.

Co-occurring conditions are screened at the same visit. The PHQ-9 flags comorbid depression, which shifts SSRI selection and dosing. The ASRS screens for adult ADHD, which is frequently misread as anxiety. When a substance use disorder is present, the ASAM Criteria dimensions determine whether outpatient anxiety work can proceed safely or whether stabilization is required first.

SSRI pharmacotherapy at anxiety-appropriate doses

Sertraline, escitalopram, paroxetine, and fluoxetine are all FDA-approved for one or more anxiety disorders and remain first-line pharmacotherapy. The dosing consideration that non-specialty prescribers routinely miss is that anxiety-effective SSRI doses sit at the upper end of the depression range — sertraline 150 to 200 mg, escitalopram 20 mg, paroxetine 40 to 60 mg — reached through a deliberately slow initial titration to avoid the activation and worsened anxiety that derail early treatment. RECO’s in-house psychiatrists start low, titrate on a schedule matched to the client’s tolerability, and hold at a therapeutic dose long enough to actually judge response.

Adjuncts have specific roles. Buspirone augments SSRI response in generalized anxiety disorder. Hydroxyzine provides an as-needed option for acute distress without benzodiazepine risk. Propranolol addresses the autonomic component of situational performance anxiety. For treatment-resistant OCD, augmentation with low-dose aripiprazole is evidence-supported. Every medication decision is documented against the target scale — a client on sertraline 200 mg whose GAD-7 has not moved after eight weeks is not a client who needs more sertraline.

Exposure-based CBT is the therapy that works

Across the anxiety disorders, the evidence base points to exposure-based cognitive behavioral therapy rather than supportive talk therapy. This is not a stylistic preference. Extinction learning — the neurobiological process by which the amygdala updates its threat prediction — requires actual contact with the feared stimulus while the feared outcome fails to occur. Talking about anxiety does not produce that update. Exposure does.

RECO’s therapists run the disorder-specific protocols. For OCD, that means Exposure and Response Prevention: a structured, hierarchical, therapist-guided practice of contacting obsessional triggers while blocking the compulsion, tracked with Y-BOCS. For panic disorder, interoceptive exposure — deliberate provocation of the bodily sensations the client has catastrophized, such as breath-holding, spinning, or hyperventilation — paired with cognitive restructuring of the misinterpretation. For social anxiety, graded in-vivo exposures moving through a hierarchy the client builds with the therapist.

The group programming supports the individual exposure work rather than replacing it. Skills groups draw from CBT, ACT for values-based action in the presence of anxiety, and DBT distress tolerance for clients whose anxiety triggers self-destructive behaviors. Motivational interviewing addresses the ambivalence that surfaces when exposure gets uncomfortable, which it will.

Why we don’t lean on benzodiazepines

Alprazolam, clonazepam, and lorazepam relieve acute anxiety within minutes, and that is precisely the problem. The pharmacological mechanism that produces rapid relief — GABA-A potentiation — also blunts the emotional processing that makes exposure therapy work. A client who takes a benzodiazepine before an exposure does not consolidate the extinction learning; they learn that the pill, not their own tolerance of the sensation, kept them safe. The next exposure without the pill produces the same anxiety.

The dependence trajectory matters more in this population. A significant share of RECO’s clients carry a co-occurring substance use disorder, and benzodiazepine exposure in that context raises the risk of misuse, cross-addiction, and complicated withdrawal. When situational bridging is genuinely clinically indicated — a discrete flight, a court date, a funeral — hydroxyzine, gabapentin, or a short course of low-dose propranolol cover most cases without initiating a dependence trajectory.

What to expect on your first visit

The intake appointment runs ninety minutes to two hours. A master’s-level clinician completes the biopsychosocial and administers the GAD-7, PHQ-9, and the disorder-specific scale indicated by the presenting complaint. A board-certified psychiatrist or psychiatric nurse practitioner reviews current medications, screens for medical contributors to anxiety — thyroid, cardiac, stimulant exposure, caffeine — and, when indicated, initiates or adjusts pharmacotherapy the same day.

Level of care is determined against the ASAM Criteria dimensions and clinical severity. Most anxiety clients from Boynton Beach begin in anxiety treatment at the intensive outpatient level — three days per week, three hours per day — with a step up to PHP if function is more impaired or a step down to weekly outpatient once gains consolidate. Clients leave the first visit with a written plan, a scheduled follow-up, and a specific target on a specific scale.

Insurance and admissions from Boynton Beach

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield plans. The admissions team verifies benefits before the first appointment and communicates copay, coinsurance, and any deductible remaining in plain numbers rather than estimates. For Boynton Beach residents, the twelve-minute drive south on Federal Highway or I-95 makes daily attendance for PHP or IOP realistic; on-site parking is free and the campus is a short walk from Atlantic Avenue.

What you can expect to hear from your treatment team

• A named diagnosis — not “anxiety,” but the specific DSM-5-TR disorder driving your presentation.
• A tracked outcome measure — GAD-7, PDSS, LSAS, or Y-BOCS, scored at intake and at regular intervals.
• A medication rationale — why this SSRI, at what target dose, on what titration schedule.
• An exposure plan — what you will practice, in what order, and how progress is measured.
• A discharge criterion — a specific score, not a calendar date.

Serving residents of: Renaissance Commons, Ocean Ridge, Quantum Park, Hunters Run, Briny Breezes.